Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6QEL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,843
Award facts
- Contract value 100% obligated
- $7,842.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,842.98 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This non-set-aside, firm fixed price contract was executed on December 19, 2025, with completion scheduled for December 22, 2025. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through competitive procurement to deliver this biologic medication used primarily for rheumatoid arthritis and other inflammatory conditions. The contract reflects the contractor's established capability to fulfill DLA medical supply requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent competitively-awarded delivery orders with firm fixed pricing, supporting military healthcare systems, the Defense Health Agency, and other government agencies through its pharmaceutical prime vendor arrangement.
Quick answers
Who was awarded contract SPE2DR26F6QEL?
SPE2DR26F6QEL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F6QEL worth?
The government has obligated $7,843 on SPE2DR26F6QEL.
Is contract SPE2DR26F6QEL an order under another contract?
Yes. SPE2DR26F6QEL is a delivery order under SPE2DR25D3801, an indefinite delivery contract.
Was contract SPE2DR26F6QEL competed?
The extent of competition for SPE2DR26F6QEL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award